Meeting
2022 ASCO Quality Care Symposium
Improving cardiac monitoring in patients with early-stage breast cancer receiving cardiotoxic chemotherapy in a multidisciplinary cancer center.
Authors
Hannah DeLuna
NorthShore University Health System, Evanston, IL
Hannah DeLuna, Dmitriy Velikov, Hardik Patel, Jamie Feld, Jason Robin, Carol A. Rosenberg, Poornima Saha
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Late and Long-Term Adverse Effects
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 191)
DOI
10.1200/JCO.2022.40.28_suppl.191
Abstract #
191
Poster Bd #
A16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The evolving landscape of chemotherapy for the treatment of early-stage breast cancer from 2006-2019: Results of a retrospective cohort study.
First Author: Jenna Bhimani
Poster
2023 ASCO Annual Meeting
Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.
First Author: Lichen Tang
Poster
2023 ASCO Annual Meeting
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
First Author: Kay T Yeung
Poster
2021 ASCO Annual Meeting
Lisinopril or carvedilol in prevention of trastuzumab-induced cardiotoxicity in patients with HER2-positive early stage breast cancer: Longitudinal changes of left ventricular ejection fraction below normal levels (LVEF <50%).
First Author: Pamela N. Munster